Entering text into the input field will update the search result below

Pfizer says strong dollar could crimp ex-U.S. sales

Jan. 18, 2017 7:36 AM ETPfizer Inc. (PFE) StockPFEBy: Douglas W. House, SA News Editor5 Comments
  • Pfizer's (NYSE:PFE) group president of its Innovative Health Division Albert Bourla says a strengthening U.S. dollar will make international sales a tougher slog for U.S. companies who have a significant international presence (all medical large caps). Pfizer, for example, generates about half its sales outside of the U.S.
  • Since the election of Donald Trump, the greenback peaked on January 3, rising over 6% against rival currencies on expectations that his policies will boost growth. It has fallen a bit since then, down over 3%, on Mr. Trump's comments that the dollar is "too strong" for U.S. firms to compete with their Chinese rivals.
  • Source: Financial Times

Recommended For You

About PFE Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
PFE--
Pfizer Inc.